Abstract
Introduction
Bio-refinery processes using different species of brown seaweeds, including Saccharina 91 latissimi and Ascophyllum nodosum have been explored for mannitol isolation (20) and 92 fucoidan, alginate, sugars and biochar production (7), respectively. In addition, bio-refinery 93 scenarios were investigated with Laminaria digitata where bioethanol (21) and succinic acid 94 (22) were produced and the remaining residues analysed as potential feedstocks for biogas 95 production, biodiesel, and feed supplements (due to enriched protein and fatty acid fractions).
96
The kelp Laminaria digitata (Hudson) J.V. Lamouroux is found in North Atlantic waters and 97 is one of the most prevalent species of brown seaweed found around the UK coastline (23) . It 
128
Fucoidan was extracted following the method outlined by Black at et (25) Monosaccharide analysis of the L. digitata residue was determined by the method outlined by 147 Kostas et al (26) where 1 mL of 11 M H 2 SO 4 was added to 30 mg of seaweed in a heat 148 resistant screw cap glass tube and incubated at 37˚C for 1 h. Water (11 mL) was added to the 149 sample to dilute the acid strength to 1 M, following which, samples were incubated at 100˚C for 2 h. Liberated monosaccharides (mannitol, fucose, arabinose, galactose, glucose and xylose) were analysed by HPAEC-PAD as described in section 2.8. Refractive Index detector, Jasco, Japan) was used for detection, and the injection volume was 160 10 μL. Data were acquired using the Azur software package v. 4.6.0.0 (Datalys, France).
161
Prior to HPLC analysis, all samples and standards were filtered using Whatman GD/X 162 syringe filters (GF/C 25 mm filter diameter/1.2 μm pore size; Whatman, UK). Authentic 
Monosaccharide profile

166
The monosaccharide profile of the extracted fucoidan was obtained by following the method 167 of Rodriguez-Jasso et al (27) . Fucoidan extract (10 mg) was hydrolysed with 2 M
168
Trifluoroacetic acid (0.5 mL) at 121°C for 2 h in N 2 sealed heat resistant screw cap glass 169 tubes. The tubes were then cooled in an iced water bath before being centrifuged at 5000 rpm 170 for 5 min. Samples were then prepared for monosaccharide quantification using the HPAEC-
171
PAD method described in Section 2.8.
Sulphate content
173
The sulphate group content of the extracted fucoidan was determined using a sulphate assay the same recipe as mentioned above for both pathogen types, however contained 2 g agar.
244
The bacterial strains were taken from glycerol stocks stored at -80°C and spread onto 
× 100
Higher glucose yields obtained from the enzymatic saccharification were indicative of a more 281 effective pre-treatment. All experiments were conducted in triplicate.
Laboratory scale trial fermentations of residue hydrolysates for bioethanol
283 production 284
Hydrolysates (generated after enzyme saccharification and described in section 2.7.1) were 285 fermented using S. cerevisiae strain NCYC 2592 following the method described in Kostas et 286 al (28) . Final glucose and ethanol yields were quantified by HPAEC-PAD and HPLC (section 287 2.8). All trials were conducted in triplicate. 
Quantification of monosaccharides (HPAEC-PAD) and ethanol (HPLC)
289
The monosaccharide concentrations were quantified using Dionex ICS-3000 Reagent-Free 
Evaluation of the waste residue after fucoidan and alginate extraction
351
The composition of the waste residue following extraction can be seen in Table 3 additionally detected, suggesting that not all of the fucoidan was extracted from the L. as mannuronic and guluronic acids may have also been released (in the case that not all of the 375 alginate was extracted) but were not quantified using the analytical method applied. 
Bioethanol production
The fermentation progression and ethanol yield data using S. cerevisiae NCYC2592 are 
438
The fucoidan extract from the bio-refining process had a DPPH • inhibition value of 76.0% ± which is close to the glycosidic bond (38) . In contrast to the DPPH • assay, the extracted (ascorbic acid) and also other extracts of fucoidan obtained from the literature (Table 4) . Table 4 Comparison of DPPH antioxidant inhibition activity (%) of the extracts produced from the bio-refining process compared against the 465 reference compound ascorbic acid and also extracts of fucoidan from other studies. further research is needed to validate these findings.
Conclusion
528
The research presented in this study described the development of a feasible seaweed bio- polysaccharides were extracted, one of which displayed interesting biological activities.
533
Bioethanol was then successfully produced from the residue which remained after the 534 extraction. In addition, extracts that were generated from various streams of the process
535
(including the waste streams) displayed antimicrobial and antioxidant activities. As such,
536
characterisation of the extracts to specifically identify the bioactive compounds would be of 537 great interest to further develop this process.
538
While this study identifies significant pathways to enable the development of a L. digitata-539 based bio-refinery, there is still much more research that is required to optimise and enhance 540 the overall process efficiency. In particular, the ethanol yields in the present study were too 541 low (3 g/L) to be economically viable on a commercial scale. Laboratory for assistance with the antimicrobial assays.
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